21 CFR 524.1662b
§ 524.1662b Oxytetracycline and polymyxin B ophthalmic ointment.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 524.1662b, § 524.1662b Oxytetracycline and polymyxin B ophthalmic ointment, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87649
- Permanent ID
ys:prov:87649@1- SHA-256
51159fe19b0e32fa67e92ce61084b2354f023a634236e5913376349fdebb22ea
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each gram of the ointment contains oxytetracycline hydrochloride equivalent to 5 milligrams of oxytetracycline and 10,000 units of polymyxin B sulfate.
(b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs and cats—(1) Amount. Administer topically to the eye two to four times daily.
(2) Indications for use. For the prophylaxis and local treatment of superficial ocular infections due to oxytetracycline- and polymyxin-sensitive organisms including ocular infections due to streptococci, rickettsiae, E. coli, and A. aerogenes (such as conjunctivitis, keratitis, pinkeye, corneal ulcer, and blepharitis in dogs, cats, cattle, sheep, and horses); ocular infections due to secondary bacterial complications associated with distemper in dogs; and ocular infections due to bacterial inflammatory conditions which may occur secondary to other infectious diseases in dogs, cats, cattle, sheep, and horses.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.